EMANITA MOUNGA: Open Payments
NPI 1306322441 · WEST VALLEY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,619 in 43 payments from 19 companies in 2025. Trend: 2023 $853 · 2024 $1,499 · 2025 $1,619
Food & beverage: $1,525Education: $94
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 14 | $367 |
| Edwards Lifesciences Corporation | 1 | $202 |
| Corcept Therapeutics | 1 | $138 |
| Phathom Pharmaceuticals, Inc. | 2 | $137 |
| GlaxoSmithKline, LLC. | 3 | $131 |
| Novo Nordisk Inc | 1 | $122 |
| Astellas Pharma US Inc | 2 | $113 |
| Boston Scientific Corporation | 2 | $53 |
| ABBVIE INC. | 2 | $48 |
| Braeburn Inc. | 2 | $48 |
Products named: SUBLOCADE, SAPIEN 3 Ultra RESILIA, Korlym, VOQUEZNA, Ozempic, AREXVY, JARDIANCE, WaveWriter Alpha Prime 16.
Industry payments across UT — which companies pay providers there.
